Cardinal Health Stock News

Cardinal Health CAH has reported Q2 FY22 adjusted EPS of $1.27, down 27% Y/Y, beating the Street estimate of $1.23. Thousands of new traders are learning the ins and outs on how to find profitable t

Cardinal Health (NYSE:CAH) is scheduled to announce Q2 earnings results on Thursday, February 3rd, before market open.The consensus EPS Estimate is $1.23 (-29.3% Y/Y) and the

Johnson & Johnson and the country''s three major drug distributors agreed Tuesday to pay $590 million to Native American tribes affected by the opioid crisis, according to a proposed settlement . Why it matters: It''s the largest opioid settlement for Native Americans, the Washington Post notes. "American Indians have suffered the highest per capita rate of opioid overdose and are more likely than other group in the United States to die from drug-induced deaths," said Douglas Yankton, chair of the Spirit Lake Nation in North Dakota, in a statement, per AP . "The dollars that will flow to Tribes under this initial settlement will help fund crucial, on-reservation, culturally appropriate opioid treatment services," Yankton added. The big picture: More than 400 tribes sued the companies, alleging that they helped fuel abuse of the addictive painkillers, Bloomberg reports. By the numbers: In Tuesday''s settlement, distributors McKesson, Cardinal Health and AmerisourceBergen have agreed to pay $440 million over seven years to tribes that have been disproportionately impacted by the opioid crisis.

Drug distributor Cardinal Health Inc has agreed to pay more than $13 million to resolve allegations that it paid doctors kickbacks to purchase specialty pharmaceutical products from it rather than rivals, the U.S. Justice Department said on Monday.

Cardinal Health's (CAH) fiscal second-quarter results are likely to reflect solid performance in the Pharmaceutical segment.

Last year, Ember outlined one of the more fascinating expansions of recent vintage we've seen in the hardware space. Primarily known for its smart mugs designed to keep their contents hot, the firm to

Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com''s offering. The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

Good, Better, Great: 7 Assets To Buy In 2022

DUBLIN , Jan. 25, 2022 /PRNewswire/ -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com''s offering. The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

And if you hang onto these investments, that income could even rise over time.

These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. The post 7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022

Cardinal Health looks like a great long-term value investment current trading at 10.0x forward P/E. The company does a good job returning cash to shareholders through share repurchases of 2.1% annuall

Earnings are not as healthy as they could be.

ASH, CAH, and ESTA have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2022